STELARA conc perf 130 mg/26ml flac

7680661350015 CH-66135 L04AC05 07.15.0.

Reimbursement limitations:

STELARACU2

Colite ulcéreuse
Traitement des patients adultes atteints de colite ulcéreuse active modérée à sévère chez …

STELARA conc perf 130 mg/26ml flac
STELARA conc perf 130 mg/26ml flac
STELARA conc perf 130 mg/26ml flac
1 / 3
google

Details

Product number
6613501
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
ustekinumabum 130 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, dinatrii edetas, methioninum, aqua ad iniectabile q.s. ad solutionem pro 26 ml, natrium 2.5 µg/ml.

Articles (1)

Stelara 130 mg, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
130.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HIMDK
(N/A)
- Substance HNIDK
(N/A)
2.5 UGML Substance HBESI

Reimbursement information

Public price
CHF 3360.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2017

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
66135
Drug name
Stelara, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
LSPA
ATC Code
L04AC05
Authorization status
Z
Dispensation category
B
First authorization
02/06/2017
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Morbus Crohn, Ulcerative Colitis

Packaging details

Description (FR)
STELARA conc perf 130 mg/26ml flac
Description (DE)
STELARA Inf Konz 130 mg/26ml Durchstf
Market launch
02/06/2017
Narcotic (BTM)
No